Features of the Course of Arterial Hypertension in the Era of the COVID-19 Pandemic: Common Pathogenetic Links Between Hypertension and SARS-CoV-2-Reference-Cited by-同舟云学术

Features of the Course of Arterial Hypertension in the Era of the COVID-19 Pandemic: Common Pathogenetic Links Between Hypertension and SARS-CoV-2

Published:2024-04-30 Issue:4 Volume:64 Page:72-78
ISSN:2412-5660
Container-title:Kardiologiia
language:
Short-container-title:Kardiologiia

Author:

Berns S. A.¹^ORCID,Leontyeva M. S.²^ORCID,Tavlueva E. V.³^ORCID,Bashnyak V. S.¹^ORCID,Drapkina O. M.¹^ORCID

Affiliation:

1. National Medical Research Center of Therapy and Preventive Medicine

2. Inozemtsev Municipal Clinical Hospital

3. National Medical Research Center of Therapy and Preventive Medicine; Inozemtsev Municipal Clinical Hospital

Abstract

The aim of this review was to present the mechanism of infection with severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) and its possible effect on the course of arterial hypertension. Another aim was to evaluate the relationship of the renin-angiotensin-aldosterone system with the pathogenetic stages of infection caused by SARS-CoV-2 virus.

Publisher

APO Society of Specialists in Heart Failure

Reference45 articles.

1. World Health Organization. Coronavirus disease (COVID-19) pandemic. [Internet] Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019

2. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. [Internet] Available at: https://covid19.who.int

3. United Nations. WHO: 1.28 billion people suffer from hypertension, more than half of them are not receiving treatment. [Internet] 2021. Available at: https://news.un.org/ru/story/2021/08/1408782

4. Xu K, Cai H, Shen Y, Ni Q, Chen Y, Hu S et al. Management of COVID-19: the Zhejiang experience. Zhejiang Da Xue Xue Bao. Yi Xue Ban. 2020;49(2):147–57. DOI: 10.3785/j.issn.1008-9292.2020.02.02

5. Böger B, Fachi MM, Vilhena RO, Cobre AF, Tonin FS, Pontarolo R. Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19. American Journal of Infection Control. 2021;49(1):21–9. DOI: 10.1016/j.ajic.2020.07.011